WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$101.10
−3.67%0
Insider buys (3m)
13
Insider sells (3m)
-$1.8M
Net value (3m)
+80.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 148 | $95 |
| Sep 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 7,197 | $0.00 |
| Sep 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,648 | $94 |
| Sep 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 541 | $97 |
| Sep 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 52 | $95 |
| Sep 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 3,039 | $99 |
| Sep 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,525 | $97 |
| Sep 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 586 | $94 |
| Sep 18, 2026 | Fuchs Thomas · director | M-Exempt | 1,146 | $0.00 |
| Sep 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 18,750 | $0.00 |
| Sep 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 1,470 | $98 |
| Sep 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 1,079 | $99 |
| Sep 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 4,141 | $98 |
| Sep 11, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 2,462 | $0.00 |
| Sep 11, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 6,547 | $0.00 |
| Sep 11, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 1,285 | $84 |
| Sep 11, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 3,692 | $84 |
| Sep 3, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 717 | $0.00 |
| Sep 3, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 372 | $84 |
| Jul 1, 2026 | GARDNER MARK A · officer: President | A-Award | 35,441 | $0.00 |
| Jun 23, 2026 | RUCH JOSHUA · director | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Ryan Jason · director | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | PFENNIGER RICHARD C JR · director | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Fuchs Thomas · director | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Meister Keith A. · director, 10 percent owner: | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | PFENNIGER RICHARD C JR · director | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | Meister Keith A. · director, 10 percent owner: | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Casdin Eli · director, 10 percent owner: | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | RUCH JOSHUA · director | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | Leproust Emily M. · director | A-Award | 4,248 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 97Increased 188Reduced 136Sold out 75
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Corvex Management LP | Increased | 4,784,570 | Aug 14, 2026 |
| Casdin Capital, LLC | Increased | 3,707,164 | Aug 14, 2026 |
| CORVEX MANAGEMENT LP | Increased | 3,228,149 | May 15, 2026 |
| CASDIN CAPITAL, LLC | Unchanged | 3,007,164 | May 15, 2026 |
| BlackRock, Inc. | Increased | 1,706,239 | Aug 7, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 1,669,441 | Aug 14, 2026 |
| ARK Investment Management LLC | Increased | 1,610,189 | Aug 14, 2026 |
| BLACKROCK, INC. | Reduced | 1,550,708 | May 13, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | Increased | 1,400,653 | Aug 12, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | Increased | 1,369,108 | May 11, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,334,980 | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Increased | 1,324,583 | May 12, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 1,220,502 | Mar 25, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,045,962 | Sep 2, 2026 |
| MORGAN STANLEY | Increased | 988,297 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 18, 2026